Showing results (511-520 of 908) with videos related to
Sort By:
Pageof 91
Lancet (London, England)|August 28, 1976
Detection of Serratia outbreaks in hospitalJ J Farmer, B R Davis, F W Hickman, et al.Cancer Research|November 1, 1978
Phase 1 clinical investigation of 4'-(9-acridinylamino)methanesulfon-m-anisidide (NSC 249992), a new acridine derivativeS S Legha, J U Gutterman, S W Hall, et al.Cancer|April 1, 1981
Effect of schedule on activity and toxicity of 5-azacytidine in acute leukemia: a Southwest Oncology Group StudyJ H Saiki, G P Bodey, J S Hewlett, et al.Cancer Chemotherapy and Pharmacology|January 1, 1978
Clinical, toxicological, and pharmacological studies of combination chemotherapy of adenocarcinoma with adriamycin and Baker's antifolateS W Hall, T F Tenczynski, R S Benjamin, et al.Journal of Neuro-Oncology|January 1, 1983
A phase II trial of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea (PCNU, NSC 95466) in recurrent malignant brain tumorsL G Feun, D J Stewart, M E Leavens, et al.Blood|September 1, 1981
Treatment of patients over 50 years of age with acute myelogenous leukemia with a combination of rubidazone and cytosine arabinoside, vincristine, and prednisone (ROAP)M J Keating, K B McCredie, R S Benjamin, et al.The American Journal of Medicine|January 1, 1996
Randomized comparison between antibiotics alone and antibiotics plus granulocyte-macrophage colony-stimulating factor (Escherichia coli-derived in cancer patients with fever and neutropeniaE J Anaissie, S Vartivarian, G P Bodey, et al.Cancer Treatment Reports|August 1, 1978
Protection against chemotherapy toxicity by IV hyperalimentationB F Issell, M Valdivieso, H A Zaren, et al.Cancer Treatment Reports|March 1, 1978
Phase II study of cis-dichlorodiammineplatinum(II) in advanced breast cancerH Y Yap, P Salem, G N Hortobagyi, et al.The Journal of Infectious Diseases|August 1, 1995
Safety, plasma concentrations, and efficacy of high-dose fluconazole in invasive mold infectionsE J Anaissie, D P Kontoyiannis, C Huls, et al.Pageof 91